The primary endpoint will be safety and tolerability. Secondary and exploratory endpoints will include serum neutralizing titers and clinical efficacy. Cohort B participants will be randomized 2:1 to ...
An antibody titer test identifies and measures the amount of antibodies in your blood, which indicates the strength of your immune response. Doctors use this test to determine if you’ve had past ...
Whether you're welcoming home a new baby, flying to a new destination for a vacation or working around sick patients as a doctor or nurse, your immunity is your invisible armor against all the bugs ...
Reported positive initial Phase 1 VYD222 clinical trial data, including favorable safety data and robust serum neutralizing titers from all three dose levels tested Plans to pursue rapid initiation of ...